Drug Information

Drug General Information
Drug ID
D0Z8IJ
Former ID
DNC000971
Drug Name
Muscimol
Drug Type
Small molecular drug
Indication Discovery agent Phase 1 [467594], [522693]
Structure
Download
2D MOL

3D MOL
Formula
C4H6N2O2
InChI
InChI=1S/C4H6N2O2/c5-2-3-1-4(7)6-8-3/h1H,2,5H2,(H,6,7)
InChIKey
ZJQHPWUVQPJPQT-UHFFFAOYSA-N
CAS Number
CAS 94421-68-8
PubChem Compound ID
4266
PubChem Substance ID
10509, 459806, 3139249, 4361986, 6760829, 7980044, 8152653, 11111210, 11113437, 14769298, 15119776, 17390897, 24886040, 24896662, 26751672, 29223366, 47365327, 47885527, 47885528, 48110574, 49846996, 49987798, 50104370, 50190956, 53789535, 56312681, 56312683, 57322218, 85087948, 90341084, 91615052, 99233254, 99376490, 103174986, 104305902, 119525667, 124749838, 124880177, 124880178, 124880179, 125329583, 125333830, 126547189, 126600947, 126678915, 127351452, 129912243, 132506066, 134339902, 134340249
ChEBI ID
ChEBI:2700
Target and Pathway
Target(s) Gamma-aminobutyric acid receptor Target Info Agonist [537788]
Glutamate receptor AMPA subtype Target Info Agonist [535527]
References
Ref 467594(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4259).
Ref 522693ClinicalTrials.gov (NCT00921128) Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease. U.S. National Institutes of Health.
Ref 535527GABA(A) receptor ligands and their therapeutic potentials. Curr Top Med Chem. 2002 Aug;2(8):817-32.
Ref 537788THIP treatment of Huntington's disease. Neurology. 1983 May;33(5):637-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.